Why should young investigators join the CLL community?
Constantine Tam et al.
Safety analysis of the BCL-2 inhibitor venetoclax for CLL
'Off the shelf' virus-specific T cells
How does a patient’s personal situation affect CLL treatment choice?
Overview of the CLLR3 trial of obinutuzumab